Archives of Medical Research
Volume 41, Issue 3 , Pages 221-225 , April 2010

IL-23: A Promising Therapeutic Target for Systemic Lupus Erythematosus

  • Rui-Xue Leng

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, PR China
    • These authors contributed equally to this work.
    • ,
  • Hai-Feng Pan

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, PR China
    • These authors contributed equally to this work.
    • ,
  • Gui-Mei Chen

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, PR China
    • ,
  • Chao Wang

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, PR China
    • ,
  • Wei-Zi Qin

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, PR China
    • ,
  • Li-Li Chen

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, PR China
    • ,
  • Jin-Hui Tao

      Affiliations

    • Department of Rheumatology, Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui, PR China
    • ,
  • Dong-Qing Ye

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, PR China
    • Corresponding Author InformationAddress reprint requests to: Dong-Qing Ye, M.D., Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui, 230032, PR China; Phone: +86 551 5167726; FAX: +86 551 5161171

Received 22 October 2009 ,Accepted 5 February 2010.

References 

  1. Illei GG, Tackey E, Lapteva L, et al. Biomarkers in systemic lupus erythematosus. II. Markers of disease activity. Arthritis Rheum. 2004;50:2048–2065
  2. Pan HF, Ye DQ, Li XP. Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2008;4:352–353
  3. Ooi JD, Phoon RK, Holdsworth SR, et al. IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. J Am Soc Nephrol. 2009;20:980–989
  4. Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003;421:744–748
  5. Murphy CA, Langrish CL, Chen Y, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003;198:1951–1957
  6. Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007;80:273–290
  7. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;314:1461–1463
  8. Oliver J, Rueda B, Lopez-Nevot MA, et al. Replication of an association between IL23R gene polymorphism with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:977–981
  9. Cornelissen F, van Hamburg JP, Lubberts E. The IL-12/IL-23 axis and its role in Th17 cell development, pathology and plasticity in arthritis. Curr Opin Investig Drugs. 2009;10:452–462
  10. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest. 2006;116:1218–1222
  11. Zhang Z, Kyttaris VC, Tsokos GC. The role of IL-23/IL-17 axis in lupus nephritis. J Immunol. 2009;183:3160–3169
  12. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8:345–350
  13. Bettelli E, Korn T, Oukka M, et al. Induction and effector functions of T(H)17 cells. Nature. 2008;453:1051–1057
  14. Langrish CL, McKenzie BS, de Waal Wilson NJ, et al. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev. 2004;202:96–105
  15. Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol. 2007;25:221–242
  16. Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39:1329–1337
  17. Sáfrány E, Pazár B, Csöngei V, et al. Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjögren syndrome in Hungarian population samples. Scand J Immunol. 2009;70:68–74
  18. Hölscher C. The power of combinatorial immunology: IL-12 and IL- 12-related dimeric cytokines in infectious diseases. Med Microbiol Immunol (Berl). 2004;193:1–17
  19. Yoshida A, Koide Y, Uchijima M, et al. IFN-γ induces IL-12 mRNA expression by a murine macrophage cell line, J774. Biochem Biophys Res Commun. 1994;198:857–861
  20. Lankford CS, Frucht DM. A unique role for IL-23 in promoting cellular immunity. J Leukocyte Biol. 2003;73:49–56
  21. Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL- 12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715–725
  22. Hölscher C. Targeting IL-23 in autoimmunity. Curr Opin Investig Drugs. 2005;6:489–495
  23. Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007;8:950–957
  24. Chen Z, Tato CM, Muul L, et al. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum. 2007;56:2936–2946
  25. Parham C, Chirica M, Timans J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12R β1 and a novel cytokine receptor subunit, IL-23R. J Immunol. 2002;168:5699–5708
  26. Cheung PF, Wong CK, Lam CW. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol. 2008;180:5625–5635
  27. Kanda N, Watanabe S. IL-12, IL-23, and IL-27 enhance human β-defensin-2 production in human keratinocytes. Eur J Immunol. 2008;38:1287–1296
  28. Jacobson NG, Szabo SJ, Guler ML, et al. Regulation of interleukin-12 signal transduction during T helper phenotype development. Res Immunol. 1995;146:446–456
  29. Elson CO, Cong Y, Weaver CT, et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell mediated model in mice. Gastroenterology. 2007;132:2359–2370
  30. Harris TJ, Grosso JF, Yen HR, et al. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol. 2007;179:4313–4317
  31. Mathur AN, Chang HC, Zisoulis DG, et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol. 2007;178:4901–4907
  32. Yang XO, Panopoulos AD, Nurieva R, et al. STAT3 regulates cytokinemediated generation of inflammatory helper T cells. J Biol Chem. 2007;282:9358–9363
  33. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORgammat. Nat Immunol. 2008;9:641–649
  34. Pène J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol. 2008;180:7423–7430
  35. McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol. 2007;8:1390–1397
  36. Gocke AR, Cravens PD, Ben LH, et al. T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J Immunol. 2007;178:1341–1348
  37. Egwuagu CE, Sztein J, Mahdi RM, et al. IFN-γ increases the severity and accelerates the onset of experimental autoimmune uveitis in transgenic rats. J Immunol. 1999;162:510–517
  38. Haas C, Ryffel B, Le Hir M. IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J Immunol. 1997;158:5484–5491
  39. Nakae S, Nambu A, Sudo K, et al. suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003;171:6173–6177
  40. Huber AK, Jacobson EM, Jazdzewski K, et al. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab. 2008;93:1077–1081
  41. Sutton CE, Lalor SJ, Sweeney CM, et al. Interleukin-1 and IL-23 induce innate IL-17 production from gamma delta T cells, amplifying Th17 responses and autoimmunity. Immunity. 2009;31:331–341
  42. Cheng F, Guo Z, Xu H, et al. Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis. 2009;68:604–606
  43. Liang SC, Tan XY, Luxenberg DP, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006;203:2271–2279
  44. Zheng Y, Danilenko DM, Valdez P, et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445:648–651
  45. Wong CK, Lit LC, Tam LS, et al. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in autoimmunity. Clin Immunol. 2008;127:385–393
  46. Huang XF, Hua J, Shen N, et al. Dysregulated expression of interleukin-23 and interleukin-12 subunits in systemic lupus erythematosus patients. Mod Rheumatol. 2007;17:220–223
  47. Hillyer P, Larché MJ, Bowman EP, et al. Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis. Rheumatology. 2009;48:1581–1589
  48. Kwan BC, Tam LS, Lai KB, et al. The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus. Rheumatology. 2009;48:1491–1497
  49. Sanchez E, Rueda B, Callejas JL, et al. Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus. Tissue Antigens. 2007;70:233–237
  50. Kim HS, Kim I, Kim JO, et al. No association between interleukin 23 receptor gene polymorphisms and systemic lupus erythematosus. Rheumatol Int. 2009;30:33–38
  51. Mannon PJ, Fuss IJ, Mayer L, et al. Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med. 2004;351:2069–2079
  52. Chen Y, Langrish CL, McKenzie B, et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest. 2006;116:1317–1326

PII: S0188-4409(10)00025-1

doi: 10.1016/j.arcmed.2010.02.011

Archives of Medical Research
Volume 41, Issue 3 , Pages 221-225 , April 2010

Article Tools